SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-121253"
 

Search: onr:"swepub:oai:DiVA.org:uu-121253" > Genetic variants an...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus

Feng, Di (author)
Stone, Rivka C. (author)
Eloranta, Maija-Leena (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Systemic Autoimmunity,Uppsala University
show more...
Sangster-Guity, Niquiche (author)
Nordmark, Gunnel (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Systemic Autoimmunity
Sigurdsson, Snaevar (author)
Uppsala universitet,Institutionen för medicinska vetenskaper
Wang, Chuan (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Molecular Medicine
Alm, Gunnar (author)
Swedish University of Agricultural Sciences,Sveriges lantbruksuniversitet,Institutionen för molekylär biovetenskap,Department of Molecular Biosciences
Syvänen, Ann-Christine (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Molecular Medicine
Rönnblom, Lars (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Systemic Autoimmunity
Barnes, Betsy J. (author)
show less...
 (creator_code:org_t)
 
Wiley, 2010
2010
English.
In: Arthritis and Rheumatism. - : Wiley. - 0004-3591 .- 1529-0131. ; 62:2, s. 562-573
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • OBJECTIVE: Genetic variants of the interferon (IFN) regulatory factor 5 gene (IRF5) are associated with susceptibility to systemic lupus erythematosus (SLE). The contribution of these variants to IRF-5 expression in primary blood cells of SLE patients has not been addressed, nor has the role of type I IFNs. The aim of this study was to determine the association between increased IRF-5 expression and the IRF5 risk haplotype in SLE patients. METHODS: IRF-5 transcript and protein levels in 44 Swedish patients with SLE and 16 healthy controls were measured by quantitative real-time polymerase chain reaction, minigene assay, and flow cytometry. Single-nucleotide polymorphisms rs2004640, rs10954213, and rs10488631 and the CGGGG insertion/deletion were genotyped in these patients. Genotypes of these polymorphisms defined both a common risk haplotype and a common protective haplotype. RESULTS: IRF-5 expression and alternative splicing were significantly up-regulated in SLE patients compared with healthy donors. Enhanced transcript and protein levels were associated with the risk haplotype of IRF5; rs10488631 displayed the only significant independent association that correlated with increased transcription from the noncoding first exon 1C. Minigene experiments demonstrated an important role for rs2004640 and the CGGGG insertion/deletion, along with type I IFNs, in regulating IRF5 expression. CONCLUSION: This study provides the first formal proof that IRF-5 expression and alternative splicing are significantly up-regulated in primary blood cells of patients with SLE. Furthermore, the risk haplotype is associated with enhanced IRF-5 transcript and protein expression in patients with SLE.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Keyword

IRF5
type I IFN
interferon
lupus
SLE
Rheumatology
Reumatologi
Medicin
Medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view